SELECT MEDICAL HOLDINGS CORP SEM Cash Flow

Select medical holdings corp (SEM)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Operating activities
Net income
218,135	201,031	187,082	185,731	186,304	176,942	268,278	250,423	241,164	220,645	120,068	99,236	88,789	125,270	130,636	159,454	158,655	135,996	137,667	133,153	131,093	128,175	131,779	128,690	120,574	123,009	133,234	133,185	148,123	153,893	149,883	151,106	119,947	112,762	0	0	0
Adjustments to reconcile net income to net cash provided by operating activities:
Distributions from unconsolidated subsidiaries
20,829	20,222	18,596	19,039	22,229	15,721	16,198	16,903	16,459	20,006	18,873	19,370	17,082	20,476	18,300	25,956	22,246	13,969	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization
212,190	212,576	212,705	210,291	207,022	201,655	189,389	177,634	164,243	160,011	157,068	155,461	153,333	145,311	142,200	136,507	122,150	104,981	88,013	74,125	69,473	68,354	67,529	66,108	64,819	64,392	64,019	63,393	62,914	63,311	65,915	67,923	70,494	71,517	0	0	0
Provision for expected credit losses
1,670	3,038	2,614	1,753	1,379	-103	78,204	78,848	78,795	79,491	-50,145	-32,637	-15,084	532	67,720	68,330	63,099	59,372	55,353	47,423	46,252	44,600	42,484	41,389	39,120	37,423	34,881	36,818	38,001	39,055	42,948	43,458	47,372	51,347	0	0	0
Equity in earnings of unconsolidated subsidiaries
23,211	24,989	25,701	24,183	21,574	21,905	20,350	19,349	20,230	21,054	21,095	21,932	20,812	19,943	18,489	19,569	18,871	16,811	15,697	11,337	8,728	7,044	5,164	2,997	2,326	2,476	2,768	4,114	6,298	7,705	0	0	0	-	-	-	-
Loss on extinguishment of debt
-	-	-	-	-	3,000	484	484	412	6,527	6,527	17,380	17,380	11,626	0	0	0	-	-	-	-	-2,277	-2,277	-2,277	-19,557	-18,747	0	0	0	-	-	-	-	-	-	-	-
Gain on sale of assets and businesses
7,427	6,321	6,388	8,542	14,888	9,168	9,979	7,806	6,253	10,349	14,077	12,550	20,704	46,488	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on disposal of assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	1,724	519	501	581	2,515	2,221	2,315	5,906	3,268	3,369	8,704	4,966	0	0	0
Impairment of equity investment
-	-	-	-	-	-	-	-	-	-	-	-	-	5,339	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock compensation expense
27,099	26,451	25,582	25,028	24,654	23,326	22,232	20,925	19,625	19,284	18,716	18,509	18,023	17,413	18,665	17,365	16,562	14,985	13,039	12,860	11,430	11,186	9,021	7,616	7,439	7,033	7,090	6,615	6,165	5,677	5,017	4,544	4,106	3,725	0	0	0
Amortization of debt discount, premium and issuance costs
8,888	11,566	12,736	12,952	13,207	13,112	12,429	11,642	10,844	11,130	12,357	14,553	15,387	15,656	14,642	12,593	11,305	9,543	8,648	7,731	7,431	7,553	7,577	7,694	8,180	8,433	8,579	8,643	8,113	7,566	0	0	0	-	-	-	-
Deferred income taxes
2,010	-7,435	2,062	2,618	7,058	7,217	-68,290	-72,541	-68,821	-72,324	-5,629	-779	-12,541	-12,591	-8,221	-10,916	-3,062	-2,058	4,542	8,608	11,783	14,311	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities, net of effects of business combinations:
Amortization of debt discount
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Accounts receivable
37,167	57,991	62,345	25,524	-25,634	-54,575	30,388	62,016	124,733	197,191	73,291	67,612	49,864	-29,241	84,570	47,403	69,926	92,572	93,656	102,818	72,175	97,802	30,832	67,562	76,619	67,145	63,572	38,154	486	-15,158	40,167	60,406	73,310	111,126	0	0	0
Other current assets
-3,291	4,259	-106	10,377	2,730	4,152	6,000	-4,143	-273	-1,597	-2,679	-882	-2,269	-17,450	-14,171	-16,546	-10,981	2,503	6,800	6,832	4,509	1,729	34	5,208	4,904	8,167	7,400	5,889	3,595	1,607	3,290	1,302	2,544	1,201	0	0	0
Other assets
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other assets
-	-	-	-	-	-7,857	-2,535	-1,177	-15,795	886	-5,551	-9,403	-10,133	-9,290	-5,319	-5,653	-2,159	-4,713	-6,704	-6,927	-5,498	103	2,540	7,090	6,770	3,484	-1,381	-4,331	-2,163	-5,862	1,883	3,130	1,086	2,081	0	0	0
Accounts payable
-7,573	5,743	3,098	6,354	9,098	-1,778	-3,517	-2,318	-3,061	3,903	6,173	1,119	6,242	-15,492	-18,454	-22,432	-24,309	2,345	6,768	4,579	6,597	5,997	-5,805	11,725	-681	-1,283	4,779	-3,296	-427	-6,117	2,523	7,036	7,292	20,629	0	0	0
Accrued expenses
62,006	37,298	901	8,533	-29,286	27,896	47,980	23,381	23,789	17,341	12,048	20,827	-23,330	46,292	27,480	27,125	51,636	7,200	16,694	-1,246	3,521	-16,039	1,895	23,707	17,487	9,590	27,300	-14,656	19,855	19,970	17,802	4,536	-5,749	4,888	0	0	0
Due to third party payors
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-969	-3,036	-4,448	1,637	2,429	1,186	227	0	0	0
Income taxes
0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0
Net cash provided by operating activities
447,504	445,182	379,857	410,158	485,229	494,194	489,136	414,741	344,719	238,131	195,814	208,705	179,574	346,603	285,745	311,593	282,048	208,415	221,830	203,533	224,177	170,642	229,661	212,669	188,497	192,523	219,711	201,900	278,528	298,682	267,290	252,406	230,340	217,128	0	0	0
Investing activities
Business combinations, net of cash acquired
94,418	93,705	90,145	91,492	13,895	523,134	527,277	526,586	533,183	27,390	77,346	69,195	68,889	472,206	425,987	435,150	1,471,825	1,061,628	1,049,872	1,048,754	3,522	1,211	0	0	0	-	-	-	-	-	-	-	-	899	0	0	0
Payments to Acquire Productive Assets
147,261	157,126	170,198	174,918	176,737	167,281	180,482	209,589	222,207	233,243	217,173	186,677	165,518	161,633	186,910	193,988	201,562	182,642	135,888	113,665	95,795	95,246	101,679	96,191	86,960	73,660	68,328	68,213	70,433	68,185	59,110	50,254	44,847	46,016	0	0	0
Proceeds from sale of assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	16,511	16,511	16,511	24,140	7,879	0	0	0
Investment in businesses
48,330	66,090	61,214	62,448	39,336	13,482	14,244	6,099	13,936	12,682	12,957	13,007	4,600	4,723	3,784	3,082	1,970	2,347	3,202	5,314	5,510	4,634	5,598	6,352	25,040	34,893	37,220	33,391	16,826	14,689	0	0	0	-	-	-	-
Proceeds from sale of assets and businesses
11,420	192	252	213	6,071	6,760	52,486	52,470	61,529	80,350	0	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-278,589	-316,729	-321,305	-328,645	-223,897	-697,137	-669,517	-689,804	-707,797	-192,965	-261,308	-221,451	-197,853	-554,320	-543,827	-525,991	-1,577,894	-1,211,754	-1,154,324	-1,167,733	-104,827	-101,091	-106,911	-101,579	-111,128	-107,306	-110,374	-107,612	-93,302	-72,406	-59,050	-48,968	-43,145	-54,735	0	0	0
Financing activities
Borrowings on revolving facilities
800,000	700,000	875,000	965,000	790,000	595,000	585,000	605,000	605,000	970,000	960,000	885,000	915,000	575,000	715,000	795,000	1,110,000	1,135,000	1,075,000	1,055,000	840,000	910,000	785,000	750,000	785,000	690,000	710,000	610,000	455,000	495,000	505,000	640,000	760,000	735,000	0	0	0
Net proceeds from term loans
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	298,500	0	0	0	-	-	-	-	-	-	-	-
Payments on revolving facilities
795,000	720,000	940,000	920,000	875,000	805,000	840,000	755,000	695,000	960,000	815,000	825,000	895,000	655,000	765,000	875,000	895,000	895,000	890,000	845,000	845,000	870,000	810,000	745,000	770,000	800,000	645,000	505,000	420,000	405,000	555,000	705,000	830,000	720,000	0	0	0
Proceeds from term loans
-	-	-	-	-	779,823	779,904	779,904	779,569	1,139,487	1,139,487	1,334,704	1,335,039	795,344	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on term loans
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on term loans
1,525,328	1,618,170	377,959	138,435	141,310	11,500	11,500	11,500	11,500	1,179,442	2,049,443	1,841,375	1,835,813	438,034	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revolving facility debt issuance costs
-	-	-	-	-	1,639	1,333	1,333	1,838	4,392	0	0	0	-	-	-	-	-	-	-	-	-	4,528	4,765	19,139	18,914	0	0	0	-	-	-	-	-	-	-	-
Borrowings of other debt
22,422	24,225	0	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on credit facility term loans
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	597,480	598,240	11,313	9,875	0	0	0	-	-	-	-
Net proceeds from 6.375% senior notes issuance
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	109,355	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Payments on 2005 credit facility term loans, net of premium
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	484,633	0	0	0
Repurchase of senior floating rate notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	167,300	0	0	0	-	-	-	-	-	-	-	-
Repurchase of 7 5/8% senior subordinated notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	70,000	0	0	0	-	-	-	-	-	-	-	-
Borrowings of other debt
-	-	-	-	-	-	-	-	-	46,621	0	0	0	-	26,134	25,866	13,519	13,374	13,081	12,555	9,547	9,076	13,108	14,512	15,595	15,310	11,684	9,355	8,272	8,281	7,394	7,394	7,394	7,055	0	0	0
Principal payments on other debt
32,548	30,604	29,899	26,401	25,488	25,242	23,506	21,731	21,281	20,647	21,036	21,912	22,212	21,401	0	0	0	-	-	15,944	16,190	14,673	15,063	13,210	11,610	10,834	10,345	9,883	10,258	10,295	9,070	9,104	7,333	7,499	0	0	0
Repurchase of common stock
47,222	38,531	38,506	19,568	6,715	6,837	6,790	5,042	4,719	4,753	0	0	0	-	-	-	-	-	-	-	-	130,734	129,892	129,298	111,298	11,781	11,058	10,095	31,146	46,902	87,953	116,309	96,517	72,804	0	0	0
Dividends paid to common stockholders
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13,129	26,238	39,342	52,439	53,366	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Dividends paid to Holdings
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of stock options
-	-	-	-	-	1,722	2,016	2,674	2,138	2,017	1,818	1,978	2,268	1,672	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	1,817	1,143	586	222	208	0	0	0
Equity investment by Holdings
-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Tax benefit from stock based awards
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,846	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Increase in overdrafts
-31,133	-25,083	-23,291	3,967	9,586	-4,380	4,368	-10,842	-753	-9,899	-1,229	7,656	22,299	10,746	-3,948	-859	-18,925	6,869	1,289	18,144	449	9,240	15,375	-10,269	6,269	-5,330	-6,163	-887	-6,893	1,227	-1,020	-546	9,726	-2,183	0	0	0
Dividends paid to Holdings
-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of non-controlling interests
16,701	18,447	18,288	18,288	6,351	2,926	3,922	9,355	7,888	9,982	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of non-controlling interests
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Distributions to and purchases of non-controlling interests
29,003	21,780	21,124	18,051	30,129	311,519	307,651	306,177	293,484	10,500	12,732	13,482	13,250	12,654	14,395	13,063	13,273	12,637	8,300	6,421	4,952	3,979	3,584	3,910	3,944	3,537	3,343	3,054	3,215	3,268	4,102	4,023	4,039	4,612	0	0	0
Purchase of membership interests of Concentra Group Holdings Parent (Note 4)
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) financing activities
-243,567	32,251	-83,002	-98,506	-233,200	255,572	233,494	342,293	417,550	-21,646	104,571	8,125	-1,918	292,311	303,670	267,627	1,374,666	1,014,420	944,100	986,251	-117,454	-70,516	-121,014	-116,718	-77,177	-121,042	-149,720	-107,040	-190,000	-198,175	-168,777	-195,502	-192,989	-154,715	0	0	0
Net decrease in cash and cash equivalents
-74,652	160,704	-24,450	-16,993	28,132	52,629	53,113	67,230	54,472	23,520	39,077	-4,621	-20,197	84,594	45,588	53,229	78,820	11,081	11,606	22,051	1,896	-965	1,736	-5,628	192	-35,825	-40,383	-12,752	-4,774	28,101	39,463	7,936	-5,794	7,678	0	0	0
Supplemental Information
Cash paid for interest
213,678	182,992	208,118	193,977	195,372	193,406	182,193	169,844	145,824	149,156	151,053	149,975	159,661	142,640	136,157	132,549	115,975	103,166	90,967	79,637	73,140	78,812	76,404	74,254	76,262	89,061	73,039	102,258	76,643	80,722	80,978	80,577	97,408	107,488	0	0	0
Cash paid for taxes
71,009	70,592	66,165	54,914	48,495	48,153	58,898	59,845	64,160	64,991	57,372	62,864	70,754	70,756	83,452	82,236	79,896	79,420	68,492	65,002	75,692	77,771	77,170	63,602	66,635	64,963	70,741	79,102	78,550	77,614	67,745	54,909	39,101	39,000	0	0	0
Operating lease right-of-use assets obtained in exchange for lease liabilities, excluding adoption impact of ASC Topic 842 at January 1, 2019
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Select Medical Corporation
Net income
-	-	-	-	-	-	268,278	250,423	241,164	220,645	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Distributions from unconsolidated subsidiaries
-	-	-	-	-	-	16,198	16,903	16,459	20,006	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation, Depletion and Amortization, Nonproduction
-	-	-	-	-	-	189,389	177,634	164,243	160,011	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Provision for bad debts
-	-	-	-	-	-	78,204	78,848	78,795	79,491	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income (Loss) from Equity Method Investments
-	-	-	-	-	-	20,350	19,349	20,230	21,054	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on extinguishment of debt
-	-	-	-	-	-	484	484	412	6,527	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on sale of assets and businesses
-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock compensation expense
-	-	-	-	-	-	22,232	20,925	19,625	19,284	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of debt discount, premium and issuance costs
-	-	-	-	-	-	12,429	11,642	10,844	11,130	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred income taxes
-	-	-	-	-	-	-68,290	-72,541	-68,821	-72,324	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts receivable
-	-	-	-	-	-	30,388	62,016	124,733	197,191	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other current assets
-	-	-	-	-	-	6,000	-4,143	-273	-1,597	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other assets
-	-	-	-	-	-	-2,535	-1,177	-15,795	886	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable
-	-	-	-	-	-	-3,517	-2,318	-3,061	3,903	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued expenses
-	-	-	-	-	-	47,980	23,381	23,789	17,341	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income taxes
-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by operating activities
-	-	-	-	-	-	489,136	414,741	344,719	238,131	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Business combinations, net of cash acquired
-	-	-	-	-	-	527,277	526,586	533,183	27,390	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of property and equipment
-	-	-	-	-	-	180,482	209,589	222,207	233,243	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investment in businesses
-	-	-	-	-	-	14,244	6,099	13,936	12,682	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sale of assets and businesses
-	-	-	-	-	-	52,486	52,470	61,529	80,350	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-	-	-	-	-	-	-669,517	-689,804	-707,797	-192,965	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Borrowings on revolving facilities
-	-	-	-	-	-	585,000	605,000	605,000	970,000	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on revolving facilities
-	-	-	-	-	-	840,000	755,000	695,000	960,000	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from term loans
-	-	-	-	-	-	779,904	779,904	779,569	1,139,487	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on term loans
-	-	-	-	-	-	11,500	11,500	11,500	1,179,442	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revolving facility debt issuance costs
-	-	-	-	-	-	1,333	1,333	1,838	4,392	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Borrowings of other debt
-	-	-	-	-	-	49,184	57,105	51,650	46,621	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Principal payments on other debt
-	-	-	-	-	-	23,506	21,731	21,281	20,647	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repurchase of common stock
-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividends paid to Holdings
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity investment by Holdings
-	-	-	-	-	-	2,016	2,674	2,138	2,017	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Increase (decrease) in overdrafts
-	-	-	-	-	-	4,368	-10,842	-753	-9,899	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividends paid to Holdings
-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of stock options
-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of non-controlling interests
-	-	-	-	-	-	3,922	9,355	7,888	9,982	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Distributions to and purchases of non-controlling interests
-	-	-	-	-	-	307,651	306,177	293,484	10,500	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) financing activities
-	-	-	-	-	-	233,494	342,293	417,550	-21,646	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in cash and cash equivalents
-	-	-	-	-	-	53,113	67,230	54,472	23,520	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for interest
-	-	-	-	-	-	182,193	169,844	145,824	149,156	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for taxes
-	-	-	-	-	-	58,898	59,845	64,160	64,991	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-